Argos Therapeutics, Inc. (ARGS) Sets New 12-Month Low at $0.28
The stock is now moving with a Negative distance from 200-Day Simple Moving Average of about -87.69% and has no so good Year to Date (YTD) Performance of -93.67% which means the stock is constantly adding to its value from previous fiscal year end price. Consulte Mais Informação